LAG3 Antikörper (AA 29-450)
Kurzübersicht für LAG3 Antikörper (AA 29-450) (ABIN7158613)
Target
Alle LAG3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 29-450
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Lymphocyte activation gene 3 protein (29-450AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Andere Bezeichnung
- LAG3
-
Hintergrund
-
Background: Involved in lymphocyte activation. Binds to HLA class-II antigens.
Aliases: CD223 antibody, CD223 antigen antibody, FDC protein antibody, LAG-3 antibody, Lag3 antibody, LAG3_HUMAN antibody, Lymphocyte activating 3 antibody, Lymphocyte activation gene 3 antibody, Lymphocyte activation gene 3 protein antibody, Protein FDC antibody
-
UniProt
- P18627
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-